Fondazione Toscana Gabriele Monasterio

Research site

Italy Via Aurelia Sud 309, 54100 Massa, Italy

3 trials recruiting
Familial dilated cardiomyopathy · Atrial fibrillation · Heart valve operation
Adult patients

About Specializations

Fondazione Toscana Gabriele Monasterio in Massa, Italy specialises in clinical trials of conditions such as Familial dilated cardiomyopathy, Atrial fibrillation, Heart valve operation, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Via Aurelia Sud 30954100 MassaItaly

Open in maps ↗

Recruiting now: 3 trials
Conditions studied: 3

More sites in Massa Italy

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

3 clinical trials

Familial dilated cardiomyopathy

Recruiting

Study of ALXN2350 gene therapy in adults with BAG3 mutation-associated dilated cardiomyopathy: A safety and efficacy trial

Registered drugNo placebo

Study of ALXN2350 gene therapy in adults with BAG3 mutation-associated dilated cardiomyopathy: A safety and efficacy trial

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:AAV9-CTNT-COBAG3
Sponsor:Alexion Pharmaceuticals Inc.

Contact Research Centre

Atrial fibrillation

Recruiting

Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid for Patients with Atrial Fibrillation Undergoing Left Atrial Appendage Closure

Registered drugNo placebo

Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid for Patients with Atrial Fibrillation Undergoing Left Atrial Appendage Closure

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Fondazione Toscana Gabriele Monasterio

Contact Research Centre

Heart valve operation

Recruiting

Study on the Use of Landiolol Hydrochloride and Sodium Chloride for Patients Undergoing Mitral Valve Surgery to Prevent Low-Cardiac Output Syndrome

Registered drug

Study on the Use of Landiolol Hydrochloride and Sodium Chloride for Patients Undergoing Mitral Valve Surgery to Prevent Low-Cardiac Output Syndrome

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Ospedale San Raffaele S.r.l.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites